tiprankstipranks
Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
US Market

Pharmagreen Biotech (PHBI) Stock Price & Analysis

45 Followers

PHBI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume39.72K
Average Volume (3M)N/A
Market Cap
$530.92K
Enterprise Value$840.17K
Total Cash (Recent Filing)$743.00
Total Debt (Recent Filing)$356.70K
Price to Earnings (P/E)-7.1
Beta0.84
May 21, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding663,645,739
10 Day Avg. Volume476,322
30 Day Avg. VolumeN/A
Standard Deviation0.41
R-Squared0.04
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-0.23
Price to Sales (P/S)154.95
Price to Cash Flow (P/CF)-66.90
P/FCF Ratio20.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue300.49
Enterprise Value/Gross Profit903.41
Enterprise Value/Ebitda-1.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

PHBI FAQ

What was Pharmagreen Biotech Inc.’s price range in the past 12 months?
Currently, no data Available
What is Pharmagreen Biotech Inc.’s market cap?
Currently, no data Available
When is Pharmagreen Biotech Inc.’s upcoming earnings report date?
Pharmagreen Biotech Inc.’s upcoming earnings report date is May 21, 2024 which is in 54 days.
    How were Pharmagreen Biotech Inc.’s earnings last quarter?
    Currently, no data Available
    Is Pharmagreen Biotech Inc. overvalued?
    According to Wall Street analysts Pharmagreen Biotech Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Pharmagreen Biotech Inc. pay dividends?
      Pharmagreen Biotech Inc. does not currently pay dividends.
      What is Pharmagreen Biotech Inc.’s EPS estimate?
      Pharmagreen Biotech Inc.’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Pharmagreen Biotech Inc. have?
      Pharmagreen Biotech Inc. has 663,645,750 shares outstanding.
        What happened to Pharmagreen Biotech Inc.’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Pharmagreen Biotech Inc.?
        Currently, no hedge funds are holding shares in PHBI
        ---

        Pharmagreen Biotech Stock Smart Score

        N/A
        Not Ranked
        1
        2
        3
        4
        5
        6
        7
        8
        9
        10

        Fundamentals

        Return on Equity
        Trailing 12-Months
        Asset Growth
        -46.89%
        Trailing 12-Months

        Company Description

        Pharmagreen Biotech Inc.

        Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        BioSig Technologies
        Palatin Technologies
        PharmaCyte Biotech
        Pulmatrix
        Popular Stocks
        ---
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis